Real-world experience of tocilizumab in systemic sclerosis: potential benefit on lung function for anti-topoisomerase-positive patients.
Yasir SulemanKristina Elizabeth Neergaard ClarkAlice R ColeVoon H OngChristopher P DentonPublished in: Rheumatology (Oxford, England) (2021)
Keyphrases
- systemic sclerosis
- lung function
- interstitial lung disease
- end stage renal disease
- cystic fibrosis
- ejection fraction
- newly diagnosed
- rheumatoid arthritis
- chronic obstructive pulmonary disease
- chronic kidney disease
- air pollution
- prognostic factors
- peritoneal dialysis
- systemic lupus erythematosus
- juvenile idiopathic arthritis
- human health